ClinConnect ClinConnect Logo
Search / Trial NCT05219799

Sex Disparities in Hypoxic Vasodilation and Impact of Obesity

Launched by UNIVERSITY OF MISSOURI-COLUMBIA · Jan 21, 2022

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how men and women respond differently to low oxygen levels in the body, particularly in relation to obesity and the nervous system. Researchers want to understand the reasons behind these differences, which could help improve treatments for people with obesity. The trial is currently looking for participants aged 65 to 74 who have a body mass index (BMI) over 18. However, individuals with certain health issues, such as pregnancy, diagnosed sleep apnea, or significant heart or kidney problems, among others, are not eligible to participate.

If you qualify and decide to join the trial, you can expect to be part of important research that could shed light on how obesity affects blood flow and oxygen delivery in different sexes. This study aims to gather valuable information that could lead to better health outcomes for both men and women with obesity. Your participation could make a difference in understanding these important health issues!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • BMI \>18 kg/m2
  • Exclusion Criteria:
  • Pregnancy, breastfeeding
  • Diagnosed sleep apnea or AHI \>10 events/hr
  • Current smoking/Nicotine use
  • Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy
  • Nerve/neurologic disease
  • Cardiovascular, hepatic, renal, respiratory disease
  • Blood pressure ≥140/90 mmHg
  • Diabetes, Polycystic ovarian syndrome
  • Communication barriers
  • Prescription medications, Sensitivity to lidocaine

About University Of Missouri Columbia

The University of Missouri-Columbia is a leading academic institution dedicated to advancing medical research and clinical innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving patient outcomes across a variety of health conditions. With a commitment to ethical research practices and collaboration with multidisciplinary teams, the University of Missouri-Columbia strives to translate scientific discoveries into effective therapeutic interventions, ultimately enhancing the quality of care in the communities it serves.

Locations

Columbia, Missouri, United States

Patients applied

0 patients applied

Trial Officials

Jacqueline Limberg, Ph.D.

Principal Investigator

University of Missouri-Columbia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials